Baidu
map

呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2022 ERS指南：成人哮喘的诊断

2022-02-15 欧洲呼吸学会 Eur Respir J

成人哮喘哮喘及肺康复

2022年2月，欧洲呼吸学会(ERS)发布了成人哮喘的诊断指南，虽然哮喘非常常见，但在现实世界中，成人哮喘的诊断仍具挑战。本文主要针对成人哮喘的诊断提供指导建议。

中文标题：

2022 ERS指南：成人哮喘的诊断

英文标题：

European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults

发布机构：

欧洲呼吸学会

发布日期：

2022-02-15

简要介绍：

2022年2月，欧洲呼吸学会(ERS)发布了成人哮喘的诊断指南，虽然哮喘非常常见，但在现实世界中，成人哮喘的诊断仍具挑战。本文主要针对成人哮喘的诊断提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 ERS指南：成人哮喘的诊断.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c0b3b1c0023586b4, title=2022 ERS指南：成人哮喘的诊断, enTitle=European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults, guiderFrom=Eur Respir J, authorId=0, author=, summary=2022年2月，欧洲呼吸学会(ERS)发布了成人哮喘的诊断指南，虽然哮喘非常常见，但在现实世界中，成人哮喘的诊断仍具挑战。本文主要针对成人哮喘的诊断提供指导建议。, cover=https://img.medsci.cn/2022217/1645104636482_1608702.jpg, journalId=0, articlesId=null, associationId=172, associationName=欧洲呼吸学会, associationIntro=欧洲呼吸学会（ERS）是欧洲专业学会组织，是具有广泛基础的拥有100多个国家的大约一万名成员。内容涵盖了基础科学和临床医学。, copyright=0, guiderPublishedTime=Tue Feb 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年2月，欧洲呼吸学会(ERS)发布了成人哮喘的诊断指南，虽然哮喘非常常见，但在现实世界中，成人哮喘的诊断仍具挑战。本文主要针对成人哮喘的诊断提供指导建议。</span></p>, tagList=[TagDto(tagId=36878, tagName=成人哮喘), TagDto(tagId=117807, tagName=哮喘及肺康复)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5758, appHits=221, showAppHits=0, pcHits=1110, showPcHits=5535, likes=1, shares=15, comments=12, approvalStatus=1, publishedTime=Fri Feb 18 15:21:00 CST 2022, publishedTimeString=2022-02-15, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Thu Feb 17 21:33:46 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 00:03:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ERS指南：成人哮喘的诊断.pdf)])
2022 ERS指南：成人哮喘的诊断.pdf
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1239446, encodeId=edcc12394465f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1802200015, createdName=慢川, createdTime=Thu Aug 18 09:54:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225943, encodeId=9110122594334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e48155521, createdName=ms8000001526377384, createdTime=Sun Jun 12 10:41:09 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206776, encodeId=01431206e76d6, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c43b5126205, createdName=1464761bm52暂无昵称, createdTime=Tue Mar 29 07:01:40 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204532, encodeId=b29f120453229, content=谢谢学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 09:02:33 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199713, encodeId=1e5f1199e1330, content=谢谢，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231124/fd91d920e9734e1294cfd0c801769fc5/f73f7f8747b84b76b12e1223886658ee.jpg, createdBy=32931458203, createdName=shunshun_9, createdTime=Sat Mar 05 19:39:53 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2022-08-18 慢川

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1239446, encodeId=edcc12394465f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1802200015, createdName=慢川, createdTime=Thu Aug 18 09:54:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225943, encodeId=9110122594334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e48155521, createdName=ms8000001526377384, createdTime=Sun Jun 12 10:41:09 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206776, encodeId=01431206e76d6, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c43b5126205, createdName=1464761bm52暂无昵称, createdTime=Tue Mar 29 07:01:40 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204532, encodeId=b29f120453229, content=谢谢学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 09:02:33 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199713, encodeId=1e5f1199e1330, content=谢谢，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231124/fd91d920e9734e1294cfd0c801769fc5/f73f7f8747b84b76b12e1223886658ee.jpg, createdBy=32931458203, createdName=shunshun_9, createdTime=Sat Mar 05 19:39:53 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2022-06-12 ms8000001526377384

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1239446, encodeId=edcc12394465f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1802200015, createdName=慢川, createdTime=Thu Aug 18 09:54:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225943, encodeId=9110122594334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e48155521, createdName=ms8000001526377384, createdTime=Sun Jun 12 10:41:09 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206776, encodeId=01431206e76d6, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c43b5126205, createdName=1464761bm52暂无昵称, createdTime=Tue Mar 29 07:01:40 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204532, encodeId=b29f120453229, content=谢谢学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 09:02:33 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199713, encodeId=1e5f1199e1330, content=谢谢，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231124/fd91d920e9734e1294cfd0c801769fc5/f73f7f8747b84b76b12e1223886658ee.jpg, createdBy=32931458203, createdName=shunshun_9, createdTime=Sat Mar 05 19:39:53 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2022-03-29 1464761bm52暂无昵称

    有没有中文版

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1239446, encodeId=edcc12394465f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1802200015, createdName=慢川, createdTime=Thu Aug 18 09:54:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225943, encodeId=9110122594334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e48155521, createdName=ms8000001526377384, createdTime=Sun Jun 12 10:41:09 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206776, encodeId=01431206e76d6, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c43b5126205, createdName=1464761bm52暂无昵称, createdTime=Tue Mar 29 07:01:40 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204532, encodeId=b29f120453229, content=谢谢学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 09:02:33 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199713, encodeId=1e5f1199e1330, content=谢谢，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231124/fd91d920e9734e1294cfd0c801769fc5/f73f7f8747b84b76b12e1223886658ee.jpg, createdBy=32931458203, createdName=shunshun_9, createdTime=Sat Mar 05 19:39:53 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2022-03-21 ms7000000490578574

    谢谢学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1239446, encodeId=edcc12394465f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1802200015, createdName=慢川, createdTime=Thu Aug 18 09:54:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225943, encodeId=9110122594334, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e48155521, createdName=ms8000001526377384, createdTime=Sun Jun 12 10:41:09 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206776, encodeId=01431206e76d6, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c43b5126205, createdName=1464761bm52暂无昵称, createdTime=Tue Mar 29 07:01:40 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204532, encodeId=b29f120453229, content=谢谢学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 09:02:33 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199713, encodeId=1e5f1199e1330, content=谢谢，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231124/fd91d920e9734e1294cfd0c801769fc5/f73f7f8747b84b76b12e1223886658ee.jpg, createdBy=32931458203, createdName=shunshun_9, createdTime=Sat Mar 05 19:39:53 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2022-03-05 shunshun_9

    谢谢，学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2014 JSA指南：成人哮喘

日本变态反应学会(JSA,Japanese Society of Allergology) · 2014-09-06

Baidu
map
Baidu
map
Baidu
map